Tarsus Pharmaceuticals: Strong Execution In Eye Disease Treatment (NASDAQ:TARS)
Pgiam/iStock via Getty ImagesTarsus Pharma (NASDAQ:TARS) has an approved drug for a mite infestation eye disease called Demodex blepharitis and...
Pgiam/iStock via Getty ImagesTarsus Pharma (NASDAQ:TARS) has an approved drug for a mite infestation eye disease called Demodex blepharitis and...
CCL Industries Inc. (CCL), a global leader in specialty label and packaging solutions, has reported a robust performance for the...
Galeanu Mihai Carlyle Secured Lending overview I have been covering Carlyle Secured Lending Inc. (NASDAQ:CGBD) since the early January this...
(Reuters) - Camden Property (NYSE:) Trust beat Wall Street estimates for second-quarter funds from operations (FFO) on Thursday, helped by...
GLENVIEW, Ill. - Illinois Tool Works Inc. (NYSE:) reported a modest earnings beat for the second quarter, with adjusted earnings...
Bank7 Corp. (NASDAQ:) delivered a robust financial performance in its second-quarter earnings report, achieving record profits. The company attributed its...
Risks for a correction in technology equities are increasing despite the sector’s robust fundamentals, Barclays strategists warned on Tuesday. "Fundamentally,...
Marlon Trottmann We are finally beginning to see some bifurcation in the AI arms race. While capex and corporate investment...
PM Images There are reasons to like HealthEquity, Inc. (NASDAQ:HQY). We have previously outlined several winning trades for the public...